A phase I dose escalation study of epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitor CP-358,774 in patients (pts) with advanced solid tumors
Year: 2000
Type: article
Source: Lung Cancer
Authors: D.D Karp, K.J Ferrante, T.G Tensfeldt, R.L Thurer, J LoCicero, M.S Huberman, F Wirth, R Hellman, P Poulin, S.L Silberman, P Redifer, L.F Allen, M Posner, L.E Schnipper
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2060433771